Programme information
- Title:
- Advanced Therapy Medicinal Products (ATMP)
- Description:
-
Health Education England elearning for healthcare (HEE elfh) has worked in partnership with a range of health organisations including the Advanced Therapy Treatment Centre Network and London Advanced Therapies to develop a new elearning programme for healthcare professionals on advanced therapies.
Advanced therapy medicinal products (ATMPs) are medicines for human use which use genes, tissues or cells to offer ground-breaking new opportunities for the treatment of disease and injury. They can offer the promise of treating and altering the course of diseases which cannot be addressed adequately by existing pharmaceuticals, offering a lifeline to some patients who may have exhausted all other treatment options.
This programme of elearning sessions is designed give the learner a core understanding of cell and gene therapies, the biology involved in these treatments and how they work. The modules take the learner from the basics of cell and gene therapy and different modalities of treatment, to an in-depth look at treatments currently being delivered through commissioned treatment and clinical trials.
Learners will also be introduced to the unique challenges of bringing these pioneering advanced therapy treatments to patients, including logistical and handling requirements.
The sessions, which each last approximately 30-45 minutes, cover the following topics:
Introduction to Advanced Therapy Medicinal Products
Focus on CAR T cell therapy
In vivo gene therapy
The logistics of ATMPs in hospitals
Introduction to Immune effector cell therapy
Advanced therapy investigational medicinal product (ATIMP) clinical trials
ISBT 128 Labels for Advanced Therapies
Procurement of cells or tissues as starting ATMP materials
Considerations of hospital pharmacy staff in delivering ATMPs
T cell receptor therapy in solid tumours
Gene Therapy Medicinal Products, GMOs and Bio-containment
Patient and public involvement and engagement (PPIE) in advanced therapy medicinal products (ATMPs) - Created:
- 30 Jun 2020
- Last Major Update:
- 30 Jun 2020
- Keywords:
- Advanced therapy, advanced therapies, ATMP, ATMPs, cell therapy, cell therapies, gene therapy, gene therapies, CAR T, CAR-T, CAR T-cell, pharmacy, nurse, transport, stem cell
Share this item
- Copy URL
- Title:
- Advanced Therapy Medicinal Products (ATMP)
- Description:
-
Health Education England elearning for healthcare (HEE elfh) has worked in partnership with a range of health organisations including the Advanced Therapy Treatment Centre Network and London Advanced Therapies to develop a new elearning programme for healthcare professionals on advanced therapies.
Advanced therapy medicinal products (ATMPs) are medicines for human use which use genes, tissues or cells to offer ground-breaking new opportunities for the treatment of disease and injury. They can offer the promise of treating and altering the course of diseases which cannot be addressed adequately by existing pharmaceuticals, offering a lifeline to some patients who may have exhausted all other treatment options.
This programme of elearning sessions is designed give the learner a core understanding of cell and gene therapies, the biology involved in these treatments and how they work. The modules take the learner from the basics of cell and gene therapy and different modalities of treatment, to an in-depth look at treatments currently being delivered through commissioned treatment and clinical trials.
Learners will also be introduced to the unique challenges of bringing these pioneering advanced therapy treatments to patients, including logistical and handling requirements.
The sessions, which each last approximately 30-45 minutes, cover the following topics:
Introduction to Advanced Therapy Medicinal Products
Focus on CAR T cell therapy
In vivo gene therapy
The logistics of ATMPs in hospitals
Introduction to Immune effector cell therapy
Advanced therapy investigational medicinal product (ATIMP) clinical trials
ISBT 128 Labels for Advanced Therapies
Procurement of cells or tissues as starting ATMP materials
Considerations of hospital pharmacy staff in delivering ATMPs
T cell receptor therapy in solid tumours
Gene Therapy Medicinal Products, GMOs and Bio-containment
Patient and public involvement and engagement (PPIE) in advanced therapy medicinal products (ATMPs) - Created:
- 30 Jun 2020
- Last Major Update:
- 30 Jun 2020
- Keywords:
- Advanced therapy, advanced therapies, ATMP, ATMPs, cell therapy, cell therapies, gene therapy, gene therapies, CAR T, CAR-T, CAR T-cell, pharmacy, nurse, transport, stem cell